Prediction of Incidence of Liver Cancer or PorTal Hypertension in Patients With Viral Hepatitis by Use of Real-time Tissue Elastography
The aim of this study is to validate the predictive value of Real-time Tissue Elastography®
by comparison with serum marker or FibroScan® in chronic hepatitis B or C patients.
Every year and for three years, we performed Real-time Tissue Elastography®, blood sampling,
gastrointestinal endoscopy. If in the hospital they can perform FibroScan®, FobroScan® also
Subjects were also performed ultrasonography (US), computed sonography (CT) or magnetic
resonance imaging (MRI) evry four or six months.
The time between the Real-time Tissue Elastography®, blood sampling, gastrointestinal
endoscopy and FiroScan® must not exceed four weeks.
Time Perspective: Prospective
Cumulative incidence of carcinogenesis of hepatocellular carcinoma
Cumulative incidence of carcinogenesis of hepatocellular carcinoma defined as the time from registration to diagnosis of hepatoceluler carcinomais
every four or six months
Masatoshi Kudo, Professor
Kinki University Faculty of Medicine
Japan: Ministry of Health, Labor and Welfare